Jasper Therapeutics Inc. (JSPR)

AI Score

Unlock

4.85

0.29 (6.36%)

At close: Apr 24, 2025, 3:59 PM

4.89

0.82%

After-hours: Apr 24, 2025, 06:22 PM EDT

Jasper Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Cash & Equivalents	71.64M	92.5M	106.82M	118.47M	86.89M	103.87M	115.81M	129.4M	38.25M	50.95M	60.81M	70.4M	84.7M	100.91M	309.73K	590.61K	19.84M	757.52K	914.25K	-27.16M	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	54.33M	100.15M
Long-Term Investments	n/a	n/a	417K	417K	417K	417K	417K	417K	417K	417K	417K	417K	345K	345K	100.13M	100.2M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.24M	1.43M	1.16M	1.42M	1.34M	411K	445K	725K	1.18M	543K	577K	611K	990K	n/a	-4.05M	-3.65M	643K	100.35M	100.42M	-27.16M	n/a
Receivables	n/a	250K	250K	250K	250K	268K	330K	n/a	n/a	384K	443K	563K	n/a	298K	n/a	n/a	600K	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	672K	1.77M	1.87M	n/a	-384K	2M	2.81M	-698K	1.19M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	4.17M	625K	475K	440K	309K	411K	653K	1.45M	1.87M	n/a	27K	54K	837K	37K	103.58K	161.65K	n/a	205.99K	267.08K	n/a	n/a
Total Current Assets	75.81M	94.81M	108.68M	120.31M	88.94M	105.22M	118.57M	132.51M	41.73M	52.41M	63.29M	73.8M	87.83M	102.41M	422.93K	756.8K	20.68M	963.51K	1.18M	27.16M	100.15M
Property-Plant & Equipment	2.85M	3.18M	3.67M	3.81M	4.19M	4.36M	4.74M	5.11M	5.45M	5.74M	6.09M	5.72M	4.83M	4.46M	4.05M	3.65M	2.03M	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	-1	n/a	n/a	n/a	-980K	n/a	n/a	n/a	-668K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	4.09M	4.61M	5.25M	5.65M	6.44M	5.19M	5.6M	6.25M	6.63M	6.7M	7.08M	6.75M	5.82M	4.81M	100.13M	100.2M	2.67M	100.35M	100.42M	-27.16M	n/a
Total Assets	79.9M	99.41M	113.93M	125.96M	95.38M	110.41M	124.17M	138.76M	48.36M	59.11M	70.37M	80.55M	93.65M	107.21M	100.55M	100.96M	23.36M	101.32M	101.6M	101.69M	100.15M
Account Payables	4.03M	3.09M	2.96M	2.39M	4.15M	3.26M	1.58M	3.85M	1.77M	3.12M	3M	1.47M	3.92M	2.25M	4.61M	1.35M	1.42M	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	1.00	n/a	n/a	7.29M	6.08M	n/a	n/a	n/a	n/a	n/a	2.81M	5.55M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.09M	n/a	n/a	n/a	972K	945K	917K	891K	n/a	840K	784K	521K	n/a	490K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	3.7M	8.31M	467K	501K	4.51M	877K	400K	1.76M	194K	1.41M	1.31M	3.01M	2.44M	1.1M	-8.41M	-3.06M	549K	180.35K	258.27K	111.36K	n/a
Total Current Liabilities	15.24M	12.46M	10.07M	8.92M	12.37M	11.91M	8.97M	7.89M	7.07M	7.42M	6.62M	5.97M	8.02M	9.16M	328.93K	180.77K	4.01M	180.35K	258.27K	111.36K	n/a
Long-Term Debt	724K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	2.26M	2.26M	2.26M	2.26M	2.26M	2.3M	2.68M	3.11M	2.52M	1.11M	1.73M	3.09M	13.74M	16.94M	11.29M	8.24M	52.85M	3.5M	3.5M	3.5M	n/a
Total Long-Term Liabilities	2.99M	3.27M	1.29M	1.55M	2.3M	4.37M	4.99M	5.67M	5.31M	4.12M	4.96M	6.47M	16.12M	19.45M	13.93M	10.92M	54.48M	3.5M	3.5M	3.5M	n/a
Total Liabilities	18.23M	15.73M	11.36M	10.47M	14.68M	16.27M	13.96M	13.56M	12.37M	11.54M	11.59M	12.44M	24.14M	28.61M	14.26M	11.1M	58.49M	3.68M	3.76M	3.61M	n/a
Total Debt	1.81M	2.07M	2.32M	2.55M	2.79M	3.01M	3.23M	3.44M	3.65M	3.85M	4.02M	3.9M	2.88M	3M	2.64M	2.68M	1.62M	n/a	n/a	n/a	n/a
Common Stock	2K	2K	2K	2K	1K	11K	11K	11K	4K	4K	4K	4K	4K	4K	81.29M	84.86M	1K	92.64M	92.84M	93.08M	n/a
Retained Earnings	-240.87M	-216.55M	-197.91M	-183.33M	-169.6M	-153.02M	-135.47M	-119.39M	-105.14M	-91.92M	-80.06M	-69.66M	-67.45M	-58.39M	-5.15M	-1.58M	-36.81M	-442.35K	-241.16K	2.04K	n/a
Comprehensive Income	n/a	n/a	n/a	0.00	n/a	n/a	-0.00	n/a	0.00	n/a	0.00	-0.00	n/a	-107.21M	0.00	-151.11M	-43.84M	n/a	n/a	-4.73M	n/a
Shareholders Equity	61.67M	83.68M	100.31M	113.23M	78.44M	94.13M	110.2M	125.2M	35.99M	47.56M	58.78M	68.11M	69.52M	78.6M	86.29M	89.86M	-35.13M	5M	5M	21.1M	n/a
Total Investments	n/a	n/a	417K	417K	417K	417K	417K	417K	417K	417K	417K	417K	345K	345K	100.13M	100.2M	n/a	n/a	n/a	54.33M	100.15M